Reply to "Global Central Nervous System Atrophy in Spinal Muscular Atrophy Type 0"

Comment

. 2019 Nov;86(5):803.

doi: 10.1002/ana.25597. Epub 2019 Oct 3.

Affiliations

¹ Department of Neurology, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, Brazil.
² Neuroradiology Section, High Diagnostic Excellence (DASA Group), São Paulo, Brazil.
³ Hernan Henriquez Aravena Regional Hospital, Temuco, Chile.
⁴ Department of Pediatric Neurology, Clínica Las Condes, Santiago, Chile.
⁵ Department of Pathology, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, Brazil.
⁶ Department of Clinical and Molecular Genetics, Valle Hebron Universitary Hospital, Medicine Genetics Group, Valle Hebron Research Institute, Barcelona, Spain.

Comment

Rodrigo H Mendonça et al. Ann Neurol. 2019 Nov.

. 2019 Nov;86(5):803.

doi: 10.1002/ana.25597. Epub 2019 Oct 3.

¹ Department of Neurology, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, Brazil.
² Neuroradiology Section, High Diagnostic Excellence (DASA Group), São Paulo, Brazil.
³ Hernan Henriquez Aravena Regional Hospital, Temuco, Chile.
⁴ Department of Pediatric Neurology, Clínica Las Condes, Santiago, Chile.
⁵ Department of Pathology, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, Brazil.
⁶ Department of Clinical and Molecular Genetics, Valle Hebron Universitary Hospital, Medicine Genetics Group, Valle Hebron Research Institute, Barcelona, Spain.

No abstract available

Comment on

Severe brain involvement in 5q spinal muscular atrophy type 0.
Mendonça RH, Rocha AJ, Lozano-Arango A, Diaz AB, Castiglioni C, Silva AMS, Reed UC, Kulikowski L, Paramonov I, Cuscó I, Tizzano EF, Zanoteli E. Mendonça RH, et al. Ann Neurol. 2019 Sep;86(3):458-462. doi: 10.1002/ana.25549. Epub 2019 Jul 24. Ann Neurol. 2019. PMID: 31301241
Global Central Nervous System Atrophy in Spinal Muscular Atrophy Type 0.
Maeda K, Chong PF, Yamashita F, Akamine S, Kawakami S, Saito K, Takahata Y, Kira R. Maeda K, et al. Ann Neurol. 2019 Nov;86(5):801-802. doi: 10.1002/ana.25596. Epub 2019 Oct 3. Ann Neurol. 2019. PMID: 31502271 No abstract available.

1. Mendonça RH, Rocha AJ, Lozano-Arango A, et al. Severe brain involvement in 5q spinal muscular atrophy type 0. Ann Neurol 2019;86:458-462.
1. Rudnik-Schöneborn S, Forkert R, Hahnen E, et al. Clinical spectrum and diagnostic criteria of infantile spinal muscular atrophy: further delineation on the basis of SMN gene deletion findings. Neuropediatrics 1996;27:8-15.
1. Medrano S, Monges S, Gravina LP, et al. Genotype-phenotype correlation of SMN locus genes in spinal muscular atrophy children from Argentina. Eur J Paediatr Neurol 2016;20:910-917.
1. Wang CH, Carter TA, Das K, et al. Extensive DNA deletion associated with severe disease alleles on spinal muscular atrophy homologues. Ann Neurol 1997;42:41-49.
1. Bernal S, Alías L, Barceló MJ, et al. The c.859G>C variant in the SMN2 gene is associated with types II and III SMA and originates from a common ancestor. J Med Genet 2010;47:640-642.